GB982072A - Benzothiadiazine-1,1-dioxides and processes for their manufacture - Google Patents
Benzothiadiazine-1,1-dioxides and processes for their manufactureInfo
- Publication number
- GB982072A GB982072A GB1012561A GB1012561A GB982072A GB 982072 A GB982072 A GB 982072A GB 1012561 A GB1012561 A GB 1012561A GB 1012561 A GB1012561 A GB 1012561A GB 982072 A GB982072 A GB 982072A
- Authority
- GB
- United Kingdom
- Prior art keywords
- rco
- formula
- amino
- sulphonamide
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention comprises compounds of the formula <FORM:0982072/C2/1> and the tautomers and alkali-metal salts thereof wherein X represents halogen or trifluoromethyl in the 6- or 7-position, Y represents hydrogen or a halogen, methyl or trifluoromethyl substituent in the 6-, 7- or 8-position and R is a saturated aliphatic hydrocarbon group of not more than 6 carbon atoms, e.g. alkyl or cycloalkyl such as cyclopropyl; and their preparation by (a) heating a compound of the formula <FORM:0982072/C2/2> wherein Z is H, benzyl or a lower aliphatic hydrocarbon group, Q may be (H,H), (H, RCO-), (RCO-, RCO-) or RC(O.lower alkyl) = and T is H or R.CO-, provided that when Z is methyl or ethyl Q is not RC(O.lower alkyl) = and that when Q and T is hydrogen, the heating is effected in the presence of a lower saturated aliphatic monocarboxylic acid R.COOH, or an ester, anhydride, acid halide or ortho ester thereof, or an a -lower alkoxy-aldehyde diacetal; (b) heating an X,Y-substituted-2-sulphamyl aniline with an ortho ester of the formula R.C(O.lower alkyl)3 or an acid RCOOH or ester, anhydride or halide thereof; (c) dehydrogenating the corresponding 3,4 - dihydro - benzothiadiazine analogue by treatment with a mild oxidizing agent such as potassium permanganate; or (d) removing hydrogen halide from a corresponding 3,4-dihydro-benzothiadiazine analogue bearing an a -haloalkyl group in place of the alkyl group R. Sulphamylanilines of the formula II are made by treating an X,Y-substituted-o-chloronitrobenzene with thiourea and benzyl chloride to give the corresponding o-benzylthio-nitrobenzene, oxidizing with chlorine to the o-nitrobenzenesulphonyl chloride, reacting with ammonia to give the sulphonamide, reducing to the o-aminobenzenesulphonamide and acylating to introduce groups RCO- on the amino and/or sulphonamido nitrogen atom, or acylating the nitrobenzenesulphonamide followed by reduction to give products acylated on the sulphonamide group only. Alternatively an X,Y-substituted o-amino-benzenesulphonamide bearing a lower aliphatic hydrocarbon or a benzyl substituent on the sulphonamide nitrogen atom may be treated an ortho ester R(COC2H5)3 to form a corresponding sulphonamide bearing an a -alkoxyalkylidene-amino substituent, e.g. R.C(OC2H5) =, in the o-position. o - Diacylamino - benzenesulphonic acids bearing substituents X and Y, in which the acyl groups are of the formula RCO-, are prepared by reacting the appropriate 2-amino-benzenesulphonic acid (e.g. 2-amino-5-chloro-benzenesulphonic acid) with an acylating agent of the formula RCOCl, (RCO)2O or R COONa (e.g. acetic anhydride). Pharmaceutical preparations having blood pressure lowering activity comprise the above compounds of the invention and a carrier suitable for enteral or parenteral administration, for example in the form of tablets, capsules, suppositories, elixirs, emulsions or injectable preparations.
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1081761A CH436314A (en) | 1960-09-19 | 1961-09-13 | Process for the production of new therapeutically active substances |
DE1961SC030290 DE1445147C3 (en) | 1960-09-19 | 1961-09-16 | 3-methyl-7-chloro-lÄ4-benzothiadiazine-l, l-dioxyde |
SE930561A SE307583B (en) | 1960-09-19 | 1961-09-19 | |
BE608298A BE608298A (en) | 1960-09-19 | 1961-09-19 | New therapeutic compounds and their manufacturing processes. |
DK371561A DK120397B (en) | 1960-09-19 | 1961-09-19 | Process for the preparation of 3-substituted 1,2,4-benzothiadiazine-1,1-dioxide compounds or salts thereof. |
DK544462A DK121233B (en) | 1961-02-20 | 1962-12-15 | Process for the preparation of 3-substituted 1,2,4-benzothiadiazine-1,1-dioxide compounds or salts thereof. |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5667160A | 1960-09-19 | 1960-09-19 | |
US8337761A | 1961-01-18 | 1961-01-18 | |
US83357A US2986573A (en) | 1961-01-18 | 1961-01-18 | Method for the treatment of hypertension |
US9019861A | 1961-02-20 | 1961-02-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB982072A true GB982072A (en) | 1965-02-03 |
Family
ID=27489824
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1012561A Expired GB982072A (en) | 1960-09-19 | 1961-03-20 | Benzothiadiazine-1,1-dioxides and processes for their manufacture |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB982072A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7572789B2 (en) | 2006-01-05 | 2009-08-11 | Essentialis, Inc. | Salts of potassium ATP channel openers and uses thereof |
US9765043B2 (en) | 2012-02-27 | 2017-09-19 | Essentialls, Inc. | Salts of potassium ATP channel openers and uses thereof |
US9782416B2 (en) | 2004-08-25 | 2017-10-10 | Essentialis, Inc. | Pharmaceutical formulations of potassium ATP channel openers and uses thereof |
-
1961
- 1961-03-20 GB GB1012561A patent/GB982072A/en not_active Expired
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9782416B2 (en) | 2004-08-25 | 2017-10-10 | Essentialis, Inc. | Pharmaceutical formulations of potassium ATP channel openers and uses thereof |
US7572789B2 (en) | 2006-01-05 | 2009-08-11 | Essentialis, Inc. | Salts of potassium ATP channel openers and uses thereof |
US7799777B2 (en) | 2006-01-05 | 2010-09-21 | Essentialis, Inc. | Salts of potassium ATP channel openers and uses thereof |
EP2404604A1 (en) | 2006-01-05 | 2012-01-11 | Essentialis, Inc. | Salts of potassium ATP channel openers and uses thereof |
US10085998B2 (en) | 2006-01-05 | 2018-10-02 | Essentialis, Inc. | Salts of potassium ATP channel openers and uses thereof |
EP3545958A1 (en) | 2006-01-05 | 2019-10-02 | Essentialis, Inc. | Salts of potassium atp channel openers and uses thereof |
US11045478B2 (en) | 2006-01-05 | 2021-06-29 | Essentialis, Inc. | Salts of potassium ATP channel openers and uses thereof |
US11786536B2 (en) | 2006-01-05 | 2023-10-17 | Essentialis, Inc. | Salts of potassium ATP channel openers and uses thereof |
US9765043B2 (en) | 2012-02-27 | 2017-09-19 | Essentialls, Inc. | Salts of potassium ATP channel openers and uses thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GEP19960467B (en) | Method of producing derivatives of quinoline or their pharmaceutically acceptable esters or acid-additive salts | |
GB1069343A (en) | Propanolamine derivatives | |
GB1331405A (en) | Esters their production and their medicinal use | |
GB1469986A (en) | Chromium salt compositions and to a process for their production | |
GB949088A (en) | Diazabicyclo-octane derivatives | |
EP0217287A3 (en) | Û(2,3,9,9a-tetrahydro-3-oxo-9a-substituted-1h-fluoren-7-yl)-oxy¨ethanimidamides and û(2,3,9,9a-tetrahydro-3-oxo-9a-substituted-1h-fluoren-7yl)oxy¨ethanimidic acid hydrazides, their derivatives and their salts | |
EP0143123A3 (en) | Industrial products useful as intermediates in the preparation of 4-hydroxy-3 quinoleine carboxamide derivatives substituted at position 2, and the preparation of these intermediates | |
GB982072A (en) | Benzothiadiazine-1,1-dioxides and processes for their manufacture | |
GB1016356A (en) | Preparation of organic peroxycarboxylic acids | |
ES274606A1 (en) | Benzoic acid ester derivatives for treating coccidiosis and method of using same | |
GB1018117A (en) | ||
GB1356437A (en) | Process for the manufacture of cephalosporanic acid derivatives and the derivatives thus obtainable | |
GB1123466A (en) | Process for the production of cyanamide dicarboxylic acid esters | |
GB898909A (en) | New naphthalene compounds and process for their manufacture | |
GB1340512A (en) | Production of esters of chromone-2-carboxylic acids | |
ES271094A1 (en) | Procedure for the obtaining of trihydroxamic acids of long chains (Machine-translation by Google Translate, not legally binding) | |
GB1088265A (en) | Process for preparing 2, 3-epithioandrostane esters | |
GB1482380A (en) | Phenylbutazone derivatives | |
GB876516A (en) | Antibacterial agents | |
GB1165633A (en) | Substituted Phenoxyfluoroacetic Acids and their preparation | |
GB1355330A (en) | Preparation of azetidin-2-one derivatives | |
GB1346401A (en) | Cardioactive arylaminobutanols | |
GB911489A (en) | Serine derivative | |
GB872708A (en) | Pyrrolo-[2, 1-ª-]-isoindoles and process for the production thereof | |
JPS51115481A (en) | Process for preparation of (3,4-dihydro-6-carbostyril)carboxylic and e ster derivatives |